Table 1.
Metabolites | Side of Origin | (Patho) Physiological Effects | Ref. |
---|---|---|---|
Metabolites Generated by Gut Bacteria | |||
p-Cresol | Colon | Intestinal epithelial cells: | |
↑LDH leakage | [32] | ||
↓ATP content | |||
↓TEER | |||
↑Paracellular transport | |||
Genotoxicity | [33] | ||
Leukocytes/Macrophages: | |||
↓IL-12 p40 production | [34] | ||
↓Respiratory burst activity | [35] | ||
Indole | Colon | Intestinal epithelial cells: | |
↑Mucin2 expression | [36,37] | ||
Regulation of gut homeostasis | [38] | ||
↓TNF-α mediated NF-κB activation | [39] | ||
↓IL-8 expression | |||
↑IL-10 expression | |||
↑TER | |||
Indole-3-acetic acid | Colon | Intestinal epithelial cells: | |
↑IL-22 expression | [40] | ||
↑Antimicrobial C-type lectin REG3G | |||
Trimethylamine | Colon | ND | |
H2S | Colon | Intestinal bacteria: | |
↑Antibiotic resistance | [53] | ||
Protection against ROS | [54] | ||
Protection against immune cells | [55] | ||
Maintenance of anaerobic conditions | |||
↓Butyrate oxidation | [56] | ||
Circulating Uremic Toxins | |||
p-Cresyl sulfate | Intestinal epithelial cells and liver | Leukocytes: | |
↑Baseline ROS and ↓ROS after stimulation | [68] | ||
↑Rolling | [70] | ||
↑Plaque growth and instability | [71] | ||
↓IFNγ-producing Th1 cells | [73] | ||
↓Anti-bacterial immune response | [74] | ||
↓Proliferation of CD43(+) B cell progenitors | [75] | ||
↑Macrophage activation | |||
↓Antigen processing | [76] | ||
Premature aging of immune cells | [77] | ||
p-Cresyl glucuronide | Intestinal epithelial cells and liver | Leukocytes: | |
Synergistic to pCS: ↑ROS, impaired blood | [69] | ||
flow; vascular leakage | [70] | ||
Indoxyl sulfate | Liver | Anti-inflammatory and tolerizing effect on | [80] |
DCs | |||
Monocytes: | |||
↑TNF-α→↑HUVEC CX3CL1 | [81] | ||
↑ROS | [82] | ||
↑Leukocyte-endothelial cell adhesion | [82,86] | ||
Macrophages: | |||
↑TNF-α | [83] | ||
↑NF-κB, ROS, mitochondrial Ca2+ | [84] | ||
overload | |||
↓Nrf2 | [85] | ||
Indole-3-acetic acid | Colon | Neutrophils: | |
↑peroxidase activity | [87] | ||
↑Glucose and glutamine metabolism | [88] | ||
↑Oxygen consumption | [88] | ||
↑Structural changes and cell death | [87,89] | ||
↑Phagocytic activity | [91] | ||
Genotoxicity | [92] | ||
Trimethylamine-oxide | Liver, kidney, and other | ↑VCAM-1 | [94] |
↑Monocyte-endothelial | |||
adhesion→↑inflammatory gene expression | |||
Activates PKC and p-NF-κB | |||
H2S | Brain, vascular tissue, liver, kidney, RBC, and other | Leukocytes: | |
↓Leukocyte-endothelial adhesion | [97,98] | ||
↓Leukocyte infiltration | |||
Regulation of post-translational | [100] | ||
modification of NF-κB pathway | |||
Macrophages: | |||
↓Pro-inflammatory cytokine production | [44] | ||
↓COX-2 and NO production | |||
↓Macrophage motitlity | |||
↓MPO activity | [101] | ||
↓Inflammation | [102] | ||
↓Antigen-binding | [103] | ||
↓Cell lysis (glomerular mesangial cells and T-lymphocytes) |
LDH: lactate dehydrogenase; ATP: adenosine triphosphate; TE(E)R: transepithelial (electrical) resistance; IL: interleukin; REG3G: regenerating islet-derived 3 gamma;ND: none described; RBC: red blood cells: ROS: reactive oxygen species; DCs: dendritic cells; HUVEC: human vascular endothelial cells; VCAM: vascular cell adhesion molecule: PKC: protein kinase C; COX: cyclooxygenase; NO: nitric oxide.; MPO: myeloperoxidase. ↓: decreased; ↑: increased.